Abbott nutritionals
This article was originally published in The Tan Sheet
Executive Summary
Firm's Ross division experienced double-digit growth in both pediatric and adult nutritional segments, with overall sales increasing 8.7% to $520 mil. in the second quarter. Abbott's infant formula business grew 12% on the strength of Similac Advance, while adult nutritionals were boosted by strong incremental sales of ZonePerfect and 20% growth in the Glucerna line. The firm expects the division to grow in the high single-digits in the second half of 2004. Abbott reported overall worldwide sales of $4.7 bil., up 14% over the prior-year period...